The high P/S ratio at Jiangsu Sihuan Bioengineering, despite...

The high P/S ratio at Jiangsu Sihuan Bioengineering, despite falling revenue and unsatisfactory medium-term growth, is a concern. Unless there's a significant medium-term turnaround, the stock might be overvalued, risking investor disappointment.